{"id":55457,"date":"2023-04-03T15:03:12","date_gmt":"2023-04-03T13:03:12","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/cultivated-meat-startup-tissenbiofarm-selected-for-samsung-welstorys-accelerating-program\/"},"modified":"2023-04-03T15:03:12","modified_gmt":"2023-04-03T13:03:12","slug":"cultivated-meat-startup-tissenbiofarm-selected-for-samsung-welstorys-accelerating-program","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/cultivated-meat-startup-tissenbiofarm-selected-for-samsung-welstorys-accelerating-program\/","title":{"rendered":"Cultivated Meat Startup TissenBioFarm Selected for SAMSUNG Welstory\u2019s Accelerating Program"},"content":{"rendered":"
\n

\n– SAMSUNG Welstory runs a startup accelerating program \u2018TechUP+\u2019 with FuturePlay<\/b><\/p>\n

\n– TissenBioFarm is the world\u2019s first company to develop mass-production technologies for whole-cut cultivated meat<\/b><\/p>\n

POHANG, South Korea–(BUSINESS WIRE)–#CellularAgriculture<\/a>—TissenBioFarm<\/a>, a cultivated meat startup based in South Korea, has been selected for the “SAMSUNG Welstory TechUP+” program. SAMSUNG Welstory<\/a> and startup accelerator FuturePlay<\/a> discover and support promising startups in the field of sustainable future food technologies through the program. Over the course of 20 weeks, TissenBioFarm will participate in an accelerating program jointly provided by SAMSUNG Welstory and FuturePlay. Follow-up collaboration projects and strategic investments may occur depending on Samsung\u2019s strategic initiatives.<\/p>\n

<\/a>
<\/a><\/p>\n

\nCultivated meat is a type of alternative protein that has recently been in the spotlight. It is a new technology that makes meat by growing animal cells outside the animal body, which eliminates the need to raise and slaughter livestock. It is considered a sustainable solution to many problems of industrial animal farming. Those include but are not limited to 1) environmental problems such as greenhouse gas emissions, water pollution, and land devastation, 2) public health risks such as antibiotics and zoonotic diseases, and 3) animal welfare problems caused by poor breeding environments.<\/p>\n

\nSAMSUNG Welstory is a food service and distribution arm of SAMSUNG Group. It has the ambition to promote cooperation with startups with its 40 years of food business capabilities and know-how. In line with the direction of pursuing ESG management, it selected startups contributing to sustainable food systems through a rigorous verification process. SAMSUNG Welstory has demonstrated great efforts for ESG management by publishing an ESG report for the first time in the Korean food distribution industry in 2021 and expanding the application of food upcycling in 2023.<\/p>\n

\nTissenBioFarm is a food technology startup that started from a tissue engineering lab of POSTECH<\/a>, Korea\u2019s top-tier research university. It has developed eco-friendly and high-quality cultivated meat using cutting-edge biotechnologies and engineering expertise. It has drawn attention by offering solutions that have overcome the industry\u2019s technical limitations such as mass production, whole-cut, meat texture, and marbling. It has developed the world’s first technology to mass-produce whole-cut cultivated meat with realistic marbles.<\/p>\n

\nWonil Han, CEO of TissenBioFarm, said, \u201cBy participating in the TechUP+ program, we aim to become a global leader in the cultivated meat field by enhancing our technologies and go-to-market strategies. We will pursue sustainable growth based on our groundbreaking proprietary technologies, and provide eco-friendly and sustainable foods to consumers through cooperation with SAMSUNG Welstory.\u201d<\/p>\n

\nTechUP+ is an open innovation program in which startup accelerator FuturePlay discovers, supports, and invests in excellent early-stage startups with big corporations. In this SAMSUNG Welstory TechUP+ program, two companies were selected through the evaluation of their technological competitiveness and business potential. FuturePlay is in charge of planning and operating the program, selecting and nurturing startups, and developing patents; while SAMSUNG Welstory provides the budget necessary for program operation, mentoring, in-house infrastructure, and follow-up investment.<\/p>\n

Contacts<\/b> <\/p>\n

\nTissenBioFarm
\n
Yeonjoo La
\n
yjla@tissenbiofarm.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

– SAMSUNG Welstory runs a startup accelerating program \u2018TechUP+\u2019 with FuturePlay – TissenBioFarm is the world\u2019s first company to develop mass-production technologies for whole-cut cultivated meat POHANG, South Korea–(BUSINESS WIRE)–#CellularAgriculture—TissenBioFarm, a cultivated meat startup based in South Korea, has been selected for the “SAMSUNG Welstory TechUP+” program. SAMSUNG Welstory and startup accelerator FuturePlay discover and … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55457","6":"format-standard","7":"category-industry"},"yoast_head":"\nCultivated Meat Startup TissenBioFarm Selected for SAMSUNG Welstory\u2019s Accelerating Program - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/cultivated-meat-startup-tissenbiofarm-selected-for-samsung-welstorys-accelerating-program\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cultivated Meat Startup TissenBioFarm Selected for SAMSUNG Welstory\u2019s Accelerating Program - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"– SAMSUNG Welstory runs a startup accelerating program \u2018TechUP+\u2019 with FuturePlay – TissenBioFarm is the world\u2019s first company to develop mass-production technologies for whole-cut cultivated meat POHANG, South Korea–(BUSINESS WIRE)–#CellularAgriculture—TissenBioFarm, a cultivated meat startup based in South Korea, has been selected for the “SAMSUNG Welstory TechUP+” program. SAMSUNG Welstory and startup accelerator FuturePlay discover and ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/cultivated-meat-startup-tissenbiofarm-selected-for-samsung-welstorys-accelerating-program\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-03T13:03:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230403005351\/en\/1753902\/21\/10kg_prototype.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cultivated-meat-startup-tissenbiofarm-selected-for-samsung-welstorys-accelerating-program\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cultivated-meat-startup-tissenbiofarm-selected-for-samsung-welstorys-accelerating-program\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Cultivated Meat Startup TissenBioFarm Selected for SAMSUNG Welstory\u2019s Accelerating Program\",\"datePublished\":\"2023-04-03T13:03:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cultivated-meat-startup-tissenbiofarm-selected-for-samsung-welstorys-accelerating-program\\\/\"},\"wordCount\":503,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cultivated-meat-startup-tissenbiofarm-selected-for-samsung-welstorys-accelerating-program\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230403005351\\\/en\\\/1753902\\\/21\\\/10kg_prototype.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cultivated-meat-startup-tissenbiofarm-selected-for-samsung-welstorys-accelerating-program\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cultivated-meat-startup-tissenbiofarm-selected-for-samsung-welstorys-accelerating-program\\\/\",\"name\":\"Cultivated Meat Startup TissenBioFarm Selected for SAMSUNG Welstory\u2019s Accelerating Program - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cultivated-meat-startup-tissenbiofarm-selected-for-samsung-welstorys-accelerating-program\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cultivated-meat-startup-tissenbiofarm-selected-for-samsung-welstorys-accelerating-program\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230403005351\\\/en\\\/1753902\\\/21\\\/10kg_prototype.jpg\",\"datePublished\":\"2023-04-03T13:03:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cultivated-meat-startup-tissenbiofarm-selected-for-samsung-welstorys-accelerating-program\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cultivated-meat-startup-tissenbiofarm-selected-for-samsung-welstorys-accelerating-program\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cultivated-meat-startup-tissenbiofarm-selected-for-samsung-welstorys-accelerating-program\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230403005351\\\/en\\\/1753902\\\/21\\\/10kg_prototype.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230403005351\\\/en\\\/1753902\\\/21\\\/10kg_prototype.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cultivated-meat-startup-tissenbiofarm-selected-for-samsung-welstorys-accelerating-program\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cultivated Meat Startup TissenBioFarm Selected for SAMSUNG Welstory\u2019s Accelerating Program\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cultivated Meat Startup TissenBioFarm Selected for SAMSUNG Welstory\u2019s Accelerating Program - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/cultivated-meat-startup-tissenbiofarm-selected-for-samsung-welstorys-accelerating-program\/","og_locale":"en_US","og_type":"article","og_title":"Cultivated Meat Startup TissenBioFarm Selected for SAMSUNG Welstory\u2019s Accelerating Program - Pharma Trend","og_description":"– SAMSUNG Welstory runs a startup accelerating program \u2018TechUP+\u2019 with FuturePlay – TissenBioFarm is the world\u2019s first company to develop mass-production technologies for whole-cut cultivated meat POHANG, South Korea–(BUSINESS WIRE)–#CellularAgriculture—TissenBioFarm, a cultivated meat startup based in South Korea, has been selected for the “SAMSUNG Welstory TechUP+” program. SAMSUNG Welstory and startup accelerator FuturePlay discover and ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/cultivated-meat-startup-tissenbiofarm-selected-for-samsung-welstorys-accelerating-program\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-03T13:03:12+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230403005351\/en\/1753902\/21\/10kg_prototype.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/cultivated-meat-startup-tissenbiofarm-selected-for-samsung-welstorys-accelerating-program\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/cultivated-meat-startup-tissenbiofarm-selected-for-samsung-welstorys-accelerating-program\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Cultivated Meat Startup TissenBioFarm Selected for SAMSUNG Welstory\u2019s Accelerating Program","datePublished":"2023-04-03T13:03:12+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cultivated-meat-startup-tissenbiofarm-selected-for-samsung-welstorys-accelerating-program\/"},"wordCount":503,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cultivated-meat-startup-tissenbiofarm-selected-for-samsung-welstorys-accelerating-program\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230403005351\/en\/1753902\/21\/10kg_prototype.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/cultivated-meat-startup-tissenbiofarm-selected-for-samsung-welstorys-accelerating-program\/","url":"https:\/\/pharma-trend.com\/en\/cultivated-meat-startup-tissenbiofarm-selected-for-samsung-welstorys-accelerating-program\/","name":"Cultivated Meat Startup TissenBioFarm Selected for SAMSUNG Welstory\u2019s Accelerating Program - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cultivated-meat-startup-tissenbiofarm-selected-for-samsung-welstorys-accelerating-program\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cultivated-meat-startup-tissenbiofarm-selected-for-samsung-welstorys-accelerating-program\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230403005351\/en\/1753902\/21\/10kg_prototype.jpg","datePublished":"2023-04-03T13:03:12+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/cultivated-meat-startup-tissenbiofarm-selected-for-samsung-welstorys-accelerating-program\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/cultivated-meat-startup-tissenbiofarm-selected-for-samsung-welstorys-accelerating-program\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/cultivated-meat-startup-tissenbiofarm-selected-for-samsung-welstorys-accelerating-program\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230403005351\/en\/1753902\/21\/10kg_prototype.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230403005351\/en\/1753902\/21\/10kg_prototype.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/cultivated-meat-startup-tissenbiofarm-selected-for-samsung-welstorys-accelerating-program\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Cultivated Meat Startup TissenBioFarm Selected for SAMSUNG Welstory\u2019s Accelerating Program"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55457","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55457"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55457\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55457"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55457"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55457"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}